throbber
111111111111111111111111111!!!111111111111111111111111111
`
`(12) United States Patent
`Brunner-Schwarz et al.
`
`(10) Patent No.:
`(45) Date of Patent:
`
`US 7,713,930 B2
`*May 11, 2010
`
`ACIDIC INSULIN PREPARATIONS HAVING
`IMPROVED STABILITY
`
`Inventors: Anette Brunner-Schwarz, Frankfurt
`(DE); Norbert Lill, Kronberg (DE)
`
`Assignee: Sanofi-Aventis Deutschland GmbH,
`Frankfurt am Main (DE)
`
`Notice:
`
`Subject to any disclaimer, the term of this
`patent is extended or adjusted under 35
`U.S.C. 154(b) by 0 days.
`
`This patent is subject to a terminal dis-
`claimer.
`
`(21) Appl. No.: 12/328,208
`
`(22) Filed:
`
`Dec. 4, 2008
`
`(65)
`
`Prior Publication Data
`
`US 2009/0082255 Al
`
`Mar. 26, 2009
`
`Related U.S. Application Data
`
`(63) Continuation of application No. 11/089,777, filed on
`Mar. 25, 2005, now Pat. No. 7,476,652, which is a
`continuation of application No. 10/461,740, filed on
`Jun. 13, 2003, now abandoned.
`
`(60) Provisional application No. 60/409,338, filed on Sep.
`9, 2002.
`
`(30)
`
`Foreign Application Priority Data
`
`Jun. 18, 2002
`
`(DE)
`
`
`
` 10227232
`
`(51) Int. Cl.
`A61K 38/28
` 514/3
`(52) U.S. Cl.
` None
`(58) Field of Classification Search
`See application file for complete search history.
`
`(2006.01)
`
`AU
`AU
`CA
`CA
`CA
`CA
`EP
`EP
`EP
`EP
`EP
`EP
`EP
`EP
`EP
`
`530/303
`
`5,474,978 A
`5,496,924 A
`5,506,203 A
`5,514,656 A
`5,534,488 A
`5,547,929 A
`5,559,094 A
`5,597,796 A
`5,614,219 A
`5,656,722 A *
`5,663,291 A
`5,693,608 A
`5,700,662 A
`5,707,641 A
`5,783,556 A
`5,824,638 A
`5,948,751 A
`5,985,309 A
`6,034,054 A
`6,043,214 A
`6,051,551 A
`6,100,376 A
`6,174,856 B1
`6,211,144 B1
`6,248,363 B1
`
`12/1995 Bakaysa et al.
`3/1996 Habermann et al.
`4/1996 Backstrom et al.
`5/1996 Chance et al.
`7/1996 Hoffmann
`8/1996 Anderson, Jr. et al.
`9/1996 Brems et al.
`1/1997 Brange
`3/1997 Wunderlich et al.
`8/1997 Dorschug
`9/1997 Obermeier et al.
`12/1997 Bechgaard et al.
`12/1997 Chance et al.
`1/1998 Gertner et al.
`7/1998 Clark et al.
`10/1998 Burnside et al.
`9/1999 Kimer et al.
`11/1999 Edwards et al.
`3/2000 DeFelippis et al.
`3/2000 Jensen et al.
`4/2000 Hughes et al.
`8/2000 Doerschug et al.
`1/2001 Langballe et al.
`4/2001 Havelund
`6/2001 Patel et al.
`
`(Continued)
`
`FOREIGN PATENT DOCUMENTS
`
`62066/86
`3/1987
`75916/87
`1/1988
`1173388
`8/1984
`1258427
`8/1989
`1336329
`7/1995
`1341203
`3/2001
`0 166 529
`1/1986
`0 180 920
`5/1986
`0 194 864
`9/1986
`0 200 383
`12/1986
`0 224 885 Al
`6/1987
`0 254 516
`1/1988
`0 383 472
`8/1990
`0419504
`1/1994
`0214826
`10/1994
`(Continued)
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`3,758,683 A
`3,868,358 A
`4,153,689 A
`4,608,364 A
`4,614,730 A
`4,644,057 A
`4,701,440 A
`4,731,405 A
`4,783,441 A
`4,839,341 A
`4,885,164 A
`4,959,351 A
`4,994,439 A
`5,008,241 A
`5,034,415 A
`5,101,013 A
`5,177,058 A
`5,358,857 A
`5,397,771 A
`5,428,006 A
`5,473,049 A
`
`9/1973
`2/1975
`5/1979
`8/1986
`9/1986
`2/1987
`10/1987
`3/1988
`11/1988
`6/1989
`12/1989
`9/1990
`2/1991
`4/1991
`7/1991
`3/1992
`1/1993
`10/1994
`3/1995
`6/1995
`12/1995
`
`Jackson
`Jackson
`Hirai et al.
`Grau
`Hansen et al.
`Bicker et al.
`Grau
`Kirsch et al.
`Thurow
`Massey et al.
`Thurow
`Grau
`Longenecker et al.
`Markussen et al.
`Rubin
`Dorschug et al.
`Dorschug
`Stengelin et al.
`Bechgaard et al.
`Bechgaard et al.
`Obermeier et al.
`
`OTHER PUBLICATIONS
`
`Brange, et al., Toward Understanding Insulin Fibrillation, Journal of
`Pharmaceutical Sciences, 86:517-525 (1997).
`
`(Continued)
`
`Primary Examiner Christopher R. Tate
`Assistant Examiner Roy Teller
`(74) Attorney, Agent, or Firm Balaram Gupta
`
`(57)
`
`ABSTRACT
`
`The invention relates to a pharmaceutical formulation com-
`prising a polypeptide selected from the group consisting of
`insulin, an insulin metabolite, an insulin analog, an insulin
`derivative and combinations thereof; a surfactant or combi-
`nations of two or more surfactants; optionally a preservative
`or combinations of two or more preservatives; and optionally
`an isotonicizing agent, buffers or further excipients or com-
`binations thereof, the pharmaceutical formulation having a
`pH in the acidic range.
`
`20 Claims, No Drawings
`
`Mylan Ex.1093
`Mylan v. Sanofi - IPR2018-01676
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket